• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

作者信息

Liang Haihai, Yu Tong, Han Yue, Jiang Hua, Wang Chengyu, You Tianyi, Zhao Xiaoguang, Shan Huitong, Yang Rui, Yang Lida, Shan Hongli, Gu Yunyan

机构信息

Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.

Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, 150081, China.

出版信息

Mol Cancer. 2021 Apr 9;20(1):64. doi: 10.1186/s12943-021-01344-4.

DOI:10.1186/s12943-021-01344-4
PMID:33836767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034128/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/230fad9b7f42/12943_2021_1344_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/39513d959183/12943_2021_1344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/ecaedf58fba0/12943_2021_1344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/230fad9b7f42/12943_2021_1344_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/39513d959183/12943_2021_1344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/ecaedf58fba0/12943_2021_1344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f955/8034128/230fad9b7f42/12943_2021_1344_Fig3_HTML.jpg

相似文献

1
Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.更正：长链非编码RNA PTAR通过竞争性结合miR-101-3p调控ZEB1表达促进浆液性卵巢癌的上皮-间质转化和侵袭转移。
Mol Cancer. 2021 Apr 9;20(1):64. doi: 10.1186/s12943-021-01344-4.
2
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.长链非编码 RNA PTAR 通过竞争性结合 miR-101-3p 调控 ZEB1 表达促进浆液性卵巢癌中的 EMT 和侵袭转移。
Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.
3
LncRNA ZEB1-AS1 reduces liver cancer cell proliferation by targeting miR-365a-3p.长链非编码RNA ZEB1-AS1通过靶向miR-365a-3p降低肝癌细胞增殖。
Exp Ther Med. 2019 May;17(5):3539-3547. doi: 10.3892/etm.2019.7358. Epub 2019 Mar 7.
4
LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.长链非编码 RNA NEAT1 通过靶向 miR-27b-3p 和 ZEB1 促进糖尿病肾病细胞外基质积累和上皮间质转化。
J Cell Physiol. 2019 Aug;234(8):12926-12933. doi: 10.1002/jcp.27959. Epub 2018 Dec 13.
5
miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.在高级别浆液性卵巢癌中，miR-1236-3p通过靶向ZEB1抑制细胞迁移和侵袭能力。
Oncol Rep. 2014 Apr;31(4):1905-10. doi: 10.3892/or.2014.3046. Epub 2014 Feb 24.
6
Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.长链非编码 RNA NORAD 通过 miR-199a-3p 调控卵巢癌细胞增殖和侵袭的机制。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1672-1681. doi: 10.26355/eurrev_202002_20341.
7
Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.长链非编码RNA MALAT1通过海绵吸附miR-143-3p调控ZEB1表达并促进肝细胞癌进展。
J Cell Biochem. 2017 Dec;118(12):4836-4843. doi: 10.1002/jcb.26158. Epub 2017 Jun 13.
8
circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.环状 CSPP1 通过作为 miR-1236-3p 的海绵吸附子促进卵巢癌细胞的增殖、侵袭和迁移。
Biomed Pharmacother. 2019 Jun;114:108832. doi: 10.1016/j.biopha.2019.108832. Epub 2019 Apr 11.
9
LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway.长链非编码RNA AC010789.1通过靶向微小RNA-432-3p/锌指E盒结合蛋白1轴和Wnt/β-连环蛋白信号通路促进结直肠癌进展。
Front Cell Dev Biol. 2020 Oct 15;8:565355. doi: 10.3389/fcell.2020.565355. eCollection 2020.
10
LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.长链非编码RNA SNHG6与胃癌的不良预后相关，并通过表观遗传沉默p27和海绵化miR-101-3p促进细胞增殖和上皮-间质转化。
Cell Physiol Biochem. 2017;42(3):999-1012. doi: 10.1159/000478682. Epub 2017 Jun 27.

引用本文的文献

1
Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis.人环状RNA hsa_circ_0001859通过miRNA-101-3p/基质金属蛋白酶1轴促进非小细胞肺癌进展。
Front Oncol. 2025 Jul 1;15:1568367. doi: 10.3389/fonc.2025.1568367. eCollection 2025.
2
Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.与肺腺癌预后及免疫细胞浸润相关的上皮-间质转化相关长链非编码RNA
Am J Transl Res. 2022 Oct 15;14(10):7308-7323. eCollection 2022.
3
Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer.

本文引用的文献

1
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.长链非编码 RNA PTAR 通过竞争性结合 miR-101-3p 调控 ZEB1 表达促进浆液性卵巢癌中的 EMT 和侵袭转移。
Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.
基于胃癌铁死亡相关长非编码 RNA 特征的亚组临床结局和潜在治疗预测。
Aging (Albany NY). 2022 Aug 14;14(15):6358-6376. doi: 10.18632/aging.204227.
4
Inhibition of lncRNA RET enhances radio-sensitivity of tumor cells via miR-3179/Slug/PTEN axis.长链非编码RNA RET的抑制通过miR-3179/Slug/PTEN轴增强肿瘤细胞的放射敏感性。
Toxicol Res (Camb). 2022 Apr 1;11(2):348-360. doi: 10.1093/toxres/tfac008. eCollection 2022 Apr.
5
Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.长链非编码 RNA UBA6-AS1 通过抑制 UBA6 mRNA 的衰减来抑制卵巢癌细胞的恶性转化。
Bioengineered. 2022 Jan;13(1):178-189. doi: 10.1080/21655979.2021.2011640.